Metformin hair loss
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Metformin and Hair Loss: Insights from Recent Research
Metformin and Hair Regrowth in Central Centrifugal Cicatricial Alopecia (CCCA)
Central Centrifugal Cicatricial Alopecia (CCCA) is a progressive scarring alopecia predominantly affecting women of African descent. Recent studies have shown promising results regarding the use of metformin for hair regrowth in CCCA patients. Metformin, commonly used for glycemic control in type 2 diabetes, has demonstrated efficacy in improving fibrosis through the mediation of adenosine monophosphate-activated protein kinase (AMPK). In two reported cases, topical application of metformin resulted in significant hair regrowth, suggesting its potential as a therapeutic option for CCCA.
Metformin's Protective Effects Against Hair Cell Death
Metformin's antioxidant properties have been explored for their potential to protect against gentamicin-induced hair cell death. In vitro studies confirmed that metformin can block the gentamicin-induced translocation of endonuclease G into the nucleus of outer hair cells, thereby attenuating hair cell loss. However, in vivo studies showed that while metformin was well tolerated, it did not prevent gentamicin-induced ototoxicity and, at higher dosages, even aggravated the condition. These findings highlight the complexity of metformin's effects on hair cells and the necessity for further research.
Metformin and Hair Follicle Regeneration
Metformin has also been shown to promote hair follicle regeneration in vitro. In a study using a mouse hair-follicle reconstitution model, metformin treatment enhanced the hair-inductive activity of three-dimensional aggregates of epidermal and dermal cells. The drug stimulated the activity of alkaline phosphatase (ALP) and upregulated the expression of several molecular markers associated with hair-inductive activity, such as hepatocyte growth factor (HGF), prominin-1 (CD133), β-catenin, and SRY-box transcription factor 2 (SOX2). These results suggest that metformin can enhance the trichogenic capacity of dermal cells, potentially offering a new avenue for treating hair loss in clinical settings.
Metformin Detection in Human Hair
A novel method has been developed to determine metformin levels in human hair using gas chromatography-tandem mass spectrometry (GC-MS/MS). This method provides a way to document chronic exposure to metformin, which can be useful in forensic toxicology and clinical monitoring. The study found that metformin is poorly incorporated into hair, with concentrations ranging from 0.3 to 3.8 ng/mg in diabetic patients under daily treatment. This method could be valuable for investigating cases of criminal poisoning or ensuring patient compliance with metformin therapy.
Conclusion
The research on metformin and hair loss presents a multifaceted picture. While metformin shows promise in promoting hair regrowth in conditions like CCCA and enhancing hair follicle regeneration in vitro, its protective effects against hair cell death in vivo are less clear. Additionally, the development of methods to detect metformin in hair opens new possibilities for clinical and forensic applications. Further studies are needed to fully understand the mechanisms and potential therapeutic uses of metformin in hair loss treatment.
Sources and full results
Most relevant research papers on this topic